her semaglutide Even With Access to Blockbuster Obesity Drugs, Some People Don't Lose Weight GLP-1 weight-loss drugs may also

Keep an eye out in early 2026 as this is expected to debut soon

Erythromycin as a motilin receptor agonist shows promise but faces limitations from tachyphylaxis and drug interactions [63]

However, when combined with GLP-1 activity to keep glucose in check, the glucagon component drives increased energy expenditure through thermogenesis, enhanced fat oxidation and breakdown, improved metabolic rate, and potential additional central appetite regulation through pathways that neither GLP-1 nor GIP can access alone

Protein shakes formulated for GLP-1 users can help you hit your protein targets when whole food meals feel overwhelming due to reduced appetite